|
1
|
Louw L: Acquired cholesteatoma
pathogenesis: Stepwise explanations. J Laryngol Otol. 124:587–593.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kuo CL, Shiao AS, Yung M, Sakagami M,
Sudhoff H, Wang CH, Hsu CH and Lien CF: Updates and knowledge gaps
in cholesteatoma research. Biomed Res Int. 2015:8540242015.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Tono T, Sakagami M, Kojima H, Yamamoto Y,
Matsuda K, Komori M, Hato N, Morita Y and Hashimoto S: Staging and
classification criteria for middle ear cholesteatoma proposed by
the Japan Otological Society. Auris Nasus Larynx. 44:135–140. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Crowson MG, Ramprasad VH, Chapurin N,
Cunningham CD III and Kaylie DM: Cost analysis and outcomes of a
second-look tympanoplasty-mastoidectomy strategy for cholesteatoma.
Laryngoscope. 126:2574–2579. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Prasad SC, Piras G, Piccirillo E, Taibah
A, Russo A, He J and Sanna M: Surgical strategy and facial nerve
outcomes in petrous bone cholesteatoma. Audiol Neurootol.
21:275–285. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Maniu A, Harabagiu O, Schrepler Perde M,
Cătană A, Fănuţă B and Mogoantă CA: Molecular biology of
cholesteatoma. Rom J Morphol Embryol. 55:7–13. 2014.PubMed/NCBI
|
|
7
|
Friedland DR, Eernisse R, Erbe C, Gupta N
and Cioffi JA: Cholesteatoma growth and proliferation:
Posttranscriptional regulation by microRNA-21. Otol Neurotol.
30:998–1005. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chen X and Qin Z: Post-transcriptional
regulation by microrna-21 and let-7a microRNA in paediatric
cholesteatoma. J Int Med Res. 39:2110–2118. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Li N and Qin ZB: Inflammation-induced
miR-802 promotes cell proliferation in cholesteatoma. Biotechnol
Lett. 36:1753–1759. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang W, Chen X and Qin Z: MicroRNA let-7a
suppresses the growth and invasion of cholesteatoma keratinocytes.
Mol Med Rep. 11:2097–2103. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bartel DP: MicroRNAs: Target recognition
and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Salmena L, Poliseno L, Tay Y, Kats L and
Pandolfi PP: A ceRNA hypothesis: The Rosetta Stone of a
hidden RNA language? Cell. 146:353–358. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bak RO and Mikkelsen JG: miRNA sponges:
Soaking up miRNAs for regulation of gene expression. Wiley
Interdiscip Rev RNA. 5:317–333. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ponting CP, Oliver PL and Reik W:
Evolution and functions of long noncoding RNAs. Cell. 136:629–641.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chen LL and Carmichael GG: Decoding the
function of nuclear long non-coding RNAs. Curr Opin Cell Biol.
22:357–364. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Rogoyski OM, Pueyo JI, Couso JP and
Newbury SF: Functions of long non-coding RNAs in human disease and
their conservation in Drosophila development. Biochem Soc Trans.
45:895–904. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Santoro M, Nociti V, Lucchini M, De Fino
C, Losavio FA and Mirabella M: Expression profile of long
non-coding RNAs in serum of patients with multiple sclerosis. J Mol
Neurosci. 59:18–23. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Elia L and Quintavalle M: Epigenetics and
vascular diseases: Influence of non-coding RNAs and their clinical
implications. Front Cardiovasc Med. 4:262017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhang X, Liu G, Qiu J, Zhang N, Ding J and
Hua K: E2F1-regulated long non-coding RNA RAD51-AS1 promotes cell
cycle progression, inhibits apoptosis and predicts poor prognosis
in epithelial ovarian cancer. Sci Rep. 7:44692017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Xu J, Qian Y, Ye M, Fu Z, Jia X, Li W, Xu
P, Lv M, Huang L, Wang L, et al: Distinct expression profile of
lncRNA in endometrial carcinoma. Oncol Rep. 36:3405–3412. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Pan B, Zhou HX, Liu Y, Yan JY, Wang Y, Yao
X, Deng YQ, Chen SY, Lu L, Wei ZJ, et al: Time-dependent
differential expression of long non-coding RNAs following
peripheral nerve injury. Int J Mol Med. 39:1381–1392. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Jiao C, Song Z, Chen J, Zhong J, Cai W,
Tian S, Chen S, Yi Y and Xiao Y: lncRNA-UCA1 enhances cell
proliferation through functioning as a ceRNA of Sox4 in esophageal
cancer. Oncol Rep. 36:2960–2966. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Sui J, Li YH, Zhang YQ, Li CY, Shen X, Yao
WZ, Peng H, Hong WW, Yin LH, Pu YP and Liang GY: Integrated
analysis of long non-coding RNAassociated ceRNA network reveals
potential lncRNA biomarkers in human lung adenocarcinoma. Int J
Oncol. 49:2023–2036. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Liu W, Ren H, Ren J, Yin T, Hu B, Xie S,
Dai Y, Wu W, Xiao Z, Yang X and Xie D: The role of
EGFR/PI3K/Akt/cyclinD1 signaling pathway in acquired middle ear
cholesteatoma. Mediators Inflamm. 2013:6512072013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ergun S, Zheng X and Carlsoo B: Expression
of transforming growth factor-alpha and epidermal growth factor
receptor in middle ear cholesteatoma. Am J Otol. 17:393–396.
1996.PubMed/NCBI
|
|
26
|
Likus W, Siemianowicz K, Markowski J,
Wiaderkiewicz J, Kostrząb-Zdebel A, Jura-Szołtys E, Dziubdziela W,
Wiaderkiewicz R and Łos MJ: Bacterial infections and
osteoclastogenesis regulators in men and women with cholesteatoma.
Arch Immunol Ther Exp. 64:241–247. 2016. View Article : Google Scholar
|
|
27
|
Huisman MA, De Heer E and Grote JJ:
Terminal differentiation and mitogen-activated protein kinase
signaling in human cholesteatoma epithelium. Otol Neurotol.
27:422–426. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Liu W, Xie S, Chen X, Rao X, Ren H, Hu B,
Yin T, Xiang Y and Ren J: Activation of the IL-6/JAK/STAT3
signaling pathway in human middle ear cholesteatoma epithelium. Int
J Clin Exp Pathol. 7:709–715. 2014.PubMed/NCBI
|
|
29
|
Hawkins PT, Anderson KE, Davidson K and
Stephens LR: Signalling through Class I PI3Ks in mammalian cells.
Biochem Soc Trans. 34:647–662. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Song G, Ouyang G and Bao S: The activation
of Akt/PKB signaling pathway and cell survival. J Cell Mol Med.
9:59–71. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Huisman MA, De Heer E and Grote JJ:
Survival signaling and terminal differentiation in cholesteatoma
epithelium. Acta Otolaryngol. 127:424–429. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Yune TY and Byun JY: Expression of PTEN
and phosphorylated Akt in human cholesteatoma epithelium. Acta
Otolaryngol. 129:501–506. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Brook I and Burke P: The management of
acute, serous and chronic otitis media: The role of anaerobic
bacteria. J Hosp Infect. 22 Suppl A:S75–S87. 1992. View Article : Google Scholar
|
|
34
|
Chen X, Li X and Qin Z: MicroRNA-21
promotes the proliferation and invasion of cholesteatoma
keratinocytes. Acta Otolaryngol. 136:1261–1266. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Humphrey SJ, James DE and Mann M: Protein
phosphorylation: A Major switch mechanism for metabolic regulation.
Trends Endocrinol Metab. 26:676–687. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Ho KY, Yeh TS, Huang HH, Hung KF, Chai CY,
Chen WT, Tsai SM, Chang NC, Chien CY, Wang HM and Wu YJ:
Upregulation of phosphorylated HSP27, PRDX2, GRP75, GRP78 and GRP94
in acquired middle ear cholesteatoma growth. Int J Mol Sci.
14:14439–14459. 2013. View Article : Google Scholar : PubMed/NCBI
|
